Related Experiment Video
Updated: Aug 15, 2026

08:26
Measuring the 50% Haemolytic Complement (CH50) Activity of Serum
Published on: March 29, 2010
Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus
1Department of Rheumatology and Clinical Immunology, University of Freiburg Medical Center, Germany.
Clinical Rheumatology
|March 1, 1993
Abstract:
In order to investigate, if complement levels can be used as an indicator of clinical activity in systemic lupus erythematosus (SLE), levels of C3, C4, CH50, and C3d were measured in 79 patients, 41 with inactive, 31 with moderately active and 7 with severely active disease. Our study shows that C3d, and particularly the C3d/C3 ratio, provide sensitive markers for disease activity in SLE. Since C3d is a direct measurement of complement turnover, it reflects complement activation better than C3, C4 and CH50.

